ArticleACS medicinal chemistry letters2019

Discovery of Selective, Orally Bioavailable Pyrazolopyridine Inhibitors of Protein Kinase Cθ (PKCθ) That Ameliorate Symptoms of Experimental Autoimmune Encephalomyelitis.

Philip N Collier et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.